RESEARCH ALERT-BMO raises ARIAD Pharmaceuticals price target

Oct 1 (Reuters) - ARIAD Pharmaceuticals Inc :

* BMO raises ARIAD Pharmaceuticals Inc price target to $36 from $31;

rating outperform

For a summary of rating and price target changes on U.S. companies:

Reuters Eikon users, click on

Reuters 3000Xtra users, double-click

Reuters Station users, click .1568

For a summary of rating and price target changes on Canadian companies:

Reuters Eikon users, click on

Reuters 3000Xtra users, double-click

Reuters Station users, click .4899

((Bangalore Equities Newsdesk [phone]; within U.S. [phone]))

((Bangalore Equities Newsdesk [phone]; within U.S. [phone]))